Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Go

Showing results (271-280 of 571) with videos related to

Pageof 58
Sort By:
Journal of the American Heart Association|October 8, 2021
Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH StudyAndrew P Ambrosy, Jingrong Yang, Sue Hee Sung, et al.
The American Journal of Cardiology|December 18, 2019
Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic MedicationsJames V Freeman, Grace H Tabada, Kristi Reynolds, et al.
Journal of the American Heart Association|April 16, 2018
Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE StudyChristine Baumgartner, Dongjie Fan, Margaret C Fang, et al.
Circulation. Heart Failure|May 28, 2013
Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure populationLarry A Allen, David J Magid, Jerry H Gurwitz, et al.
Contemporary Clinical Trials|April 10, 2008
Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunitiesCarol P Somkin, Andrea Altschuler, Lynn Ackerson, et al.
Circulation|May 8, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical TrialGregory Piazza, Alex C Spyropoulos, Judith Hsia, et al.
European Journal of Preventive Cardiology|February 21, 2021
Risk of atherosclerotic cardiovascular disease by cardiovascular health metric categories in approximately 1 million patientsJamal S Rana, Jennifer Y Liu, Howard H Moffet, et al.
Circulation. Cardiovascular Genetics|September 30, 2015
Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-CourseElias Salfati, Shuktika Nandkeolyar, Stephen P Fortmann, et al.
Thrombosis Research|March 22, 2020
Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE studyChristine Baumgartner, Alan S Go, Dongjie Fan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Deep Learning-Enabled Screening of Chronic Kidney Disease from EchocardiographyVictoria Yuan, Hirotaka Ieki, Alexander Sandhu, et al.
Pageof 58

Showing results (271-280 of 571) with videos related to

Sort By:
Pageof 58
Journal of the American Heart Association|October 8, 2021
Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH StudyAndrew P Ambrosy, Jingrong Yang, Sue Hee Sung, et al.
The American Journal of Cardiology|December 18, 2019
Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic MedicationsJames V Freeman, Grace H Tabada, Kristi Reynolds, et al.
Journal of the American Heart Association|April 16, 2018
Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE StudyChristine Baumgartner, Dongjie Fan, Margaret C Fang, et al.
Circulation. Heart Failure|May 28, 2013
Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure populationLarry A Allen, David J Magid, Jerry H Gurwitz, et al.
Contemporary Clinical Trials|April 10, 2008
Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunitiesCarol P Somkin, Andrea Altschuler, Lynn Ackerson, et al.
Circulation|May 8, 2023
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical TrialGregory Piazza, Alex C Spyropoulos, Judith Hsia, et al.
European Journal of Preventive Cardiology|February 21, 2021
Risk of atherosclerotic cardiovascular disease by cardiovascular health metric categories in approximately 1 million patientsJamal S Rana, Jennifer Y Liu, Howard H Moffet, et al.
Circulation. Cardiovascular Genetics|September 30, 2015
Susceptibility Loci for Clinical Coronary Artery Disease and Subclinical Coronary Atherosclerosis Throughout the Life-CourseElias Salfati, Shuktika Nandkeolyar, Stephen P Fortmann, et al.
Thrombosis Research|March 22, 2020
Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE studyChristine Baumgartner, Alan S Go, Dongjie Fan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Deep Learning-Enabled Screening of Chronic Kidney Disease from EchocardiographyVictoria Yuan, Hirotaka Ieki, Alexander Sandhu, et al.
Pageof 58